Biolinerx Ltd ADR (BLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 28,940 | 4,800 | 0 | 0 | 0 |
| Cost of Goods | 9,263 | 3,692 | N/A | N/A | N/A |
| Gross Profit | 19,677 | 1,108 | N/A | N/A | N/A |
| Operating Expenses | 40,348 | 51,494 | 29,157 | 24,777 | 22,927 |
| Operating Income | -20,408 | -49,694 | -29,157 | -24,777 | -22,927 |
| Interest Expense | 9,119 | 2,169 | 2,158 | 1,006 | 1,629 |
| Other Income | 20,306 | -8,751 | 6,364 | -1,271 | -5,465 |
| Pre-tax Income | -9,221 | -60,614 | -24,951 | -27,054 | -30,021 |
| Net Income Continuous | -9,221 | -60,614 | -24,951 | -27,054 | -30,021 |
| Net Income | $-9,221 | $-60,614 | $-24,951 | $-27,054 | $-30,021 |
| EPS Basic Total Ops | -6.00 | -36.00 | -18.00 | -24.00 | -72.00 |
| EPS Basic Continuous Ops | -4.62 | -37.75 | -19.34 | -24.49 | -71.24 |
| EPS Diluted Total Ops | -6.00 | -36.00 | -18.00 | -24.00 | -72.00 |
| EPS Diluted Continuous Ops | -4.62 | -37.75 | -19.34 | -24.49 | -71.24 |
| EPS Diluted Before Non-Recurring Items | -6.00 | -37.60 | -19.20 | -24.00 | -72.00 |
| EBITDA(a) | $-16,343 | $-48,310 | $-28,503 | $-24,074 | $-21,993 |